In Depth 22 Oct 2025 PCSK9’s second act: From antibodies to gene editing With Eli Lilly’s recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents. October 22, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Sep 2025 CRISPR technology’s next wave: Ten companies to watch in 2025 Driven by CASGEVY’s success, the CRISPR field is experiencing substantial growth with a new wave of companies. September 30, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Sep 2025 Resurrecting the dodo: an ethical dilemma or chance at restoring biodiversity? Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird. What are the ethical concerns? September 24, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 29 Aug 2025 Can genetically modified crops help us adapt to climate change? Find out whether genetically modified crops can help us adapt to climate change and ensure global food security. August 29, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 20 Aug 2025 From pasture to lab: The new biotech toolkit for cattle Nature writes the best horror stories – In The New York Times’ recent piece, the return of the screwworm, a flesh‑eating parasite once eradicated from the U.S. Indeed, cattle ranchers are once again staring at wounds riddled with maggots. This insect, which devastated cattle in the 20th century, is making a comeback, spurring governments to […] August 20, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2025 Beyond CRISPR: What CAST could bring to genome editing Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in research. June 6, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 21 May 2025 Layoffs in the US: what is going on with genomics companies? Genomics companies have been slashing jobs and culling programs in the US. Learn about the layoffs that have struck the industry in 2025. May 21, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 16 Apr 2025 Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy. April 16, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 15 Jan 2025 CRISPR: The gene editing tool changing the world (2025 update) CRISPR-Cas9 has changed the world with the promise of making gene editing much easier and faster than before. But what is its real potential? January 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 11 Nov 2024 Gene editing sector investment struggles: What’s driving the slowdown? Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs. November 11, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 31 Oct 2024 Halloween biotech stories: Unveiling scientists’ worst fears What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress. October 31, 2024 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 9 Aug 2024Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi. August 9, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More